MIRA Pharmaceuticals (MIRA)

• Market cap: $53.2M
• 1 day: -4.51%
• 5 days: 8.55%
• 1 month: -5.22%
• 3 months: -14.19%
• 6 months: -7.3%
• Year to date: -14.77%
• 1 year: 24.51%
• 5 years: -82.88%
• 10 years: -82.88%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Employees: 5